Cost-effectiveness analysis of therapeutic strategies for patients with chronic hepatitis C previously not responding to interferon.
about
Ribavirin plus interferon versus interferon for chronic hepatitis CCosts and cost-effectiveness of different follow-up schedules for detection of occupational hepatitis C virus infectionEstimation of utilities for chronic hepatitis C from SF-36 scores.The use of cost per life year gained as a measurement of cost-effectiveness in Spain: a systematic review of recent publications.Cost-effectiveness analysis of therapeutic options for chronic hepatitis C genotype 3 infected patients.Cost-effectiveness analysis of simeprevir with daclatasvir for non-cirrhotic genotype-1b-naïve patients plus chronic hepatitis C.Cost-effectiveness analysis of triple therapy with protease inhibitors in treatment-naive hepatitis C patients.Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C.
P2860
Q24240879-02DC8E2D-56A9-4EBB-989B-6B0BC1C3A0C5Q27487452-62B1B3CC-F4FF-4A35-8ED8-1A03C85F3D2BQ36060018-24BF1D24-77DE-4029-91C9-03966A594D5AQ37887568-23A67F6E-9208-49D6-97ED-C2001BD9487AQ40584662-6E0EA2CD-7DB5-428A-8698-AFD38C0FF665Q41434717-1B28A968-7D74-4942-9CAA-7021A1864C82Q42272479-3D6E69DB-8465-4237-9D80-380A6BDF07DBQ45050419-122695F8-9802-4F8D-8E96-277116D7537B
P2860
Cost-effectiveness analysis of therapeutic strategies for patients with chronic hepatitis C previously not responding to interferon.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Cost-effectiveness analysis of ...... not responding to interferon.
@en
Cost-effectiveness analysis of ...... not responding to interferon.
@nl
type
label
Cost-effectiveness analysis of ...... not responding to interferon.
@en
Cost-effectiveness analysis of ...... not responding to interferon.
@nl
prefLabel
Cost-effectiveness analysis of ...... not responding to interferon.
@en
Cost-effectiveness analysis of ...... not responding to interferon.
@nl
P2093
P2860
P1476
Cost-effectiveness analysis of ...... not responding to interferon.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.2003.01494.X
P407
P577
2003-03-01T00:00:00Z